JP2016532632A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016532632A5 JP2016532632A5 JP2016515425A JP2016515425A JP2016532632A5 JP 2016532632 A5 JP2016532632 A5 JP 2016532632A5 JP 2016515425 A JP2016515425 A JP 2016515425A JP 2016515425 A JP2016515425 A JP 2016515425A JP 2016532632 A5 JP2016532632 A5 JP 2016532632A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrosis
- pharmaceutically acceptable
- pharmaceutically
- stereoisomers
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 8
- 206010016654 Fibrosis Diseases 0.000 claims 6
- 230000004761 fibrosis Effects 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 238000011282 treatment Methods 0.000 claims 4
- 206010020772 Hypertension Diseases 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 206010028594 Myocardial fibrosis Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 201000002793 renal fibrosis Diseases 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 206010065918 Prehypertension Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000011461 pre-eclampsia Diseases 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013903573 | 2013-09-17 | ||
| AU2013903573A AU2013903573A0 (en) | 2013-09-17 | Compositions for the treatment of hypertension and/or fibrosis | |
| PCT/AU2014/000923 WO2015039173A1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016532632A JP2016532632A (ja) | 2016-10-20 |
| JP2016532632A5 true JP2016532632A5 (enExample) | 2016-12-08 |
| JP6122548B2 JP6122548B2 (ja) | 2017-04-26 |
Family
ID=52687998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016515425A Active JP6122548B2 (ja) | 2013-09-17 | 2014-09-17 | 高血圧及び／又は線維症の処置用組成物 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9458093B2 (enExample) |
| EP (1) | EP3046901B1 (enExample) |
| JP (1) | JP6122548B2 (enExample) |
| KR (1) | KR101736416B1 (enExample) |
| CN (1) | CN105683152B (enExample) |
| AP (1) | AP2016009079A0 (enExample) |
| AU (1) | AU2014324078B2 (enExample) |
| BR (1) | BR112016005601B1 (enExample) |
| CA (1) | CA2924356C (enExample) |
| DK (1) | DK3046901T3 (enExample) |
| ES (1) | ES2655455T3 (enExample) |
| IL (1) | IL244621A (enExample) |
| MX (1) | MX368865B (enExample) |
| MY (1) | MY172557A (enExample) |
| NO (1) | NO3046901T3 (enExample) |
| NZ (1) | NZ717927A (enExample) |
| PH (1) | PH12016500497B1 (enExample) |
| PL (1) | PL3046901T3 (enExample) |
| RU (1) | RU2635564C2 (enExample) |
| SG (1) | SG11201601642WA (enExample) |
| UA (1) | UA118111C2 (enExample) |
| WO (1) | WO2015039173A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3284981B2 (ja) | 1998-11-02 | 2002-05-27 | 株式会社デンソー | 車両用交流発電機およびそのステータの製造方法 |
| US9956166B2 (en) | 2013-09-18 | 2018-05-01 | Sorrento Therapeutics, Inc. | Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin |
| MX376504B (es) | 2015-03-18 | 2025-03-07 | Vectus Biosystems Ltd | Composiciones para el tratamiento de enfermedades renales y/o hepaticas. |
| DK3271320T3 (da) * | 2015-03-18 | 2020-02-03 | Vectus Biosystems Ltd | Sammensætninger til behandling af fibrose og fibroserelaterede tilstande |
| EP3353147B1 (en) * | 2015-09-22 | 2021-01-13 | Vectus Biosystems Limited | Synthesis of terphenyl compounds |
| IL298314B2 (en) * | 2016-04-13 | 2025-04-01 | Univ Nebraska | Methods of administration and methods of treating cardiovascular diseases with resiniparatoxin |
| BR112019001510B1 (pt) * | 2016-07-28 | 2022-11-08 | Vectus Biosystems Limited | Composto, e, uso de um composto para manufatura de um medicamento para tratar profilática ou terapeuticamente fibrose pulmonar, ou uma enfermidade relacionada em um indivíduo com fibrose pulmonar ou em risco de desenvolver fibrose pulmonar |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2694288B1 (fr) * | 1992-06-30 | 1994-09-09 | Rhone Poulenc Agrochimie | Phenylbenzamides fongicides et procédés pour les préparer. |
| ES2523659T3 (es) * | 2004-06-11 | 2014-11-28 | Vectus Biosystems Limited | Composiciones y procedimientos para el tratamiento de enfermedades cardiovasculares |
| NZ623674A (en) * | 2005-12-09 | 2014-07-25 | Vectus Biosystems Ltd | Vip fragments and methods of use |
| US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
| JP6293266B2 (ja) * | 2013-09-17 | 2018-03-14 | ヴェクタス バイオシステムズ リミテッド | 高血圧及び／又は線維症の処置用組成物 |
-
2014
- 2014-09-17 NO NO14845373A patent/NO3046901T3/no unknown
- 2014-09-17 ES ES14845373.1T patent/ES2655455T3/es active Active
- 2014-09-17 SG SG11201601642WA patent/SG11201601642WA/en unknown
- 2014-09-17 AP AP2016009079A patent/AP2016009079A0/xx unknown
- 2014-09-17 KR KR1020167008664A patent/KR101736416B1/ko active Active
- 2014-09-17 US US15/022,278 patent/US9458093B2/en active Active
- 2014-09-17 RU RU2016112257A patent/RU2635564C2/ru active
- 2014-09-17 DK DK14845373.1T patent/DK3046901T3/en active
- 2014-09-17 CA CA2924356A patent/CA2924356C/en active Active
- 2014-09-17 AU AU2014324078A patent/AU2014324078B2/en active Active
- 2014-09-17 EP EP14845373.1A patent/EP3046901B1/en active Active
- 2014-09-17 UA UAA201602267A patent/UA118111C2/uk unknown
- 2014-09-17 WO PCT/AU2014/000923 patent/WO2015039173A1/en not_active Ceased
- 2014-09-17 PL PL14845373T patent/PL3046901T3/pl unknown
- 2014-09-17 MY MYPI2016000482A patent/MY172557A/en unknown
- 2014-09-17 NZ NZ717927A patent/NZ717927A/en unknown
- 2014-09-17 CN CN201480050979.1A patent/CN105683152B/zh active Active
- 2014-09-17 JP JP2016515425A patent/JP6122548B2/ja active Active
- 2014-09-17 MX MX2016003371A patent/MX368865B/es active IP Right Grant
- 2014-09-17 BR BR112016005601-9A patent/BR112016005601B1/pt active IP Right Grant
-
2016
- 2016-03-14 PH PH12016500497A patent/PH12016500497B1/en unknown
- 2016-03-16 IL IL244621A patent/IL244621A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014507446A5 (enExample) | ||
| JP2017509667A5 (enExample) | ||
| JP2016532632A5 (enExample) | ||
| JP2017537066A5 (enExample) | ||
| JP2016518337A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2018521020A5 (enExample) | ||
| JP2012107057A5 (enExample) | ||
| JP2013014622A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| JP2017186358A5 (enExample) | ||
| JP2011105738A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| JP2013532687A5 (enExample) | ||
| EP4663636A3 (en) | Trifluoromethyl substituted pyrazoles as human plasma kallikrein inhibitors | |
| EP4643945A3 (en) | Neuroactive steroids and methods of use thereof | |
| JP2013532130A5 (enExample) | ||
| HK1244708A1 (zh) | 作爲fxr/tgr5激动剂的胆汁酸类似物及其使用方法 | |
| JP2011518833A5 (enExample) | ||
| JP2017514910A5 (enExample) | ||
| JP2017520613A5 (enExample) | ||
| JP2019516735A5 (enExample) | ||
| MX394588B (es) | Composición farmacéutica. | |
| JP2016535100A5 (enExample) | ||
| JP2016510326A5 (enExample) |